Quantinuum

Quantinuum experienced a spike-and-retreat session: after rising to an intraday high of $80.00 in pre-market trading, the stock sharply reversed at the regular open and fell to $74.33 by ET 09:38, down about 5.2% from the prior close of $78.41. The initial optimism came after multiple analysts initiated buy ratings following the IPO quiet period—Needham set a $100 price target, and Jefferies also issued positive coverage, briefly pushing the stock over 2% higher in pre-market. However, Q1 earnings revealed revenue plunged 72.56% YoY to just $5.237 million, while net loss widened to $136.6 million, yielding a net profit margin of -2,608%. The stock’s current price of $74.50 remains above its MA20/MA60 of $65.53, but at a 9.48% discount to the 52-week high of $82.30, and YTD gain has narrowed to 23.39%, suggesting that deep fundamental losses are weighing against the bullish analyst narrative.